Periodontal Diseases and Host Modulation Therapies

Area of Science:

• Periodontology
• Microbiology
• Immunology

Background:

• Periodontal diseases are initiated by bacterial pathogens, with the host's response playing a critical role.
• Current treatments focus on bacterial reduction, but host-directed therapies offer a complementary strategy.
• Host modulation therapy (HMT) aims to manage the host's inflammatory and immune responses.

Purpose of the Study:

• To review the current landscape of host modulation in treating and preventing periodontal diseases.
• To evaluate the efficacy of various HMT approaches, including pharmaceutical agents, probiotics, and immunomodulatory methods.
• To highlight the potential of HMT in improving periodontal treatment outcomes and preventing tissue damage.

Main Methods:

• Systematic review of studies evaluating host modulation strategies for periodontal diseases.
• Analysis of research on pharmaceutical agents, probiotics, and immunomodulatory interventions.
• Inclusion of studies focusing on reducing bacterial biofilm and managing host response.

Main Results:

• HMT, alongside conventional periodontal therapy, shows potential in improving disease management and reducing tissue damage.
• Strategies include reducing bacterial biofilm, managing inflammation, restoring microbiome balance, and modulating immune responses.
• Pharmaceuticals, probiotics, and immunomodulatory agents are key components of HMT.

Conclusions:

• Host modulation therapy presents a promising avenue for enhanced periodontal disease treatment and prevention.
• By targeting host response, HMT can complement traditional therapies and improve clinical outcomes.
• Further research into specific HMT agents and their mechanisms is warranted.